Chimerix, Inc.

Chimerix, Inc.

Biotechnology Research

Durham, NC 4,373 followers

About us

At Chimerix, we are on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. With a focus in oncology, we are devoted to filling gaps in the treatment paradigm.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Durham, NC
Type
Public Company

Locations

Employees at Chimerix, Inc.

Updates

  • View organization page for Chimerix, Inc., graphic

    4,373 followers

    Come visit us at the 28th Meeting of the Society for Neuro-Oncology (SNO) in Vancouver from November 16-19.  Our team will be onsite to discuss ONC201, the Phase 3 ACTION study, and how using molecular profiling to identify patients most likely to benefit from therapy is driving advances in the treatment of glioma. On Saturday, November 18th at 12:45 PM, please join us in room 205-207 for our satellite symposium to discuss the current diagnosis, treatment strategies, and clinical trials for H3 K27M-mutant diffuse glioma.

Similar pages

Browse jobs

Funding

Chimerix, Inc. 14 total rounds

Last Round

Grant

US$ 2.0M

Investors

Collaboratory
See more info on crunchbase